DOCSLIB.ORG

Proxy Vote Record

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Proxy Vote Record Company Name Ticker Country Meeting Date Proposal Text Vote Instruction Acacia Research Corporation ACTG USA 14-Feb-20 Approve the Voting of Preferred Shares on an As-Converted Basis and the Issuance of Common Stock in Connection with the For Potential Future Conversion of Series A Convertible Preferred Stock and Exercise of Warrants Acacia Research Corporation ACTG USA 14-Feb-20 Increase Authorized Common Stock For Acacia Research Corporation ACTG USA 14-Feb-20 Approve the Voting of Preferred Shares on an As-Converted Basis and the Issuance of Common Stock in Connection with the For Potential Future Conversion of Series A Convertible Preferred Stock and Exercise of Warrants Acacia Research Corporation ACTG USA 14-Feb-20 Increase Authorized Common Stock For AFI Properties Ltd. AFPR Israel 04-Feb-20 Discuss Financial Statements and the Report of the Board AFI Properties Ltd. AFPR Israel 04-Feb-20 Reelect Eitan Bar Zeev as Director For AFI Properties Ltd. AFPR Israel 04-Feb-20 Reelect Zahi Nahmias as Director For AFI Properties Ltd. AFPR Israel 04-Feb-20 Reelect Michal Kamir as Director For AFI Properties Ltd. AFPR Israel 04-Feb-20 Reelect Lea Nass as External Director For AFI Properties Ltd. AFPR Israel 04-Feb-20 Reelect Daniel Bernshtein as External Director For AFI Properties Ltd. AFPR Israel 04-Feb-20 Reappoint Kost, Forer, Gabbay and Kasierer as Auditors; Report on Fees Paid to the Auditor for 2018 Against AFI Properties Ltd. AFPR Israel 04-Feb-20 Vote FOR if you are a controlling shareholder or have a personal interest in one or several resolutions, as indicated in the proxy Against card; otherwise, vote AGAINST. You may not abstain. If you vote FOR, please provide an explanation to your account manager AFI Properties Ltd. AFPR Israel 04-Feb-20 If you are an Interest Holder as defined in Section 1 of the Securities Law, 1968, vote FOR. Otherwise, vote against. Against AFI Properties Ltd. AFPR Israel 04-Feb-20 If you are a Senior Officer as defined in Section 37(D) of the Securities Law, 1968, vote FOR. Otherwise, vote against. Against AFI Properties Ltd. AFPR Israel 04-Feb-20 If you are an Institutional Investor as defined in Regulation 1 of the Supervision Financial Services Regulations 2009 or a Manager For of a Joint Investment Trust Fund as defined in the Joint Investment Trust Law, 1994, vote FOR. Otherwise, vote against. Agricultural Bank of China 1288 China 28-Feb-20 Approve Fixed Assets Investment Budget for 2020 For Agricultural Bank of China 1288 China 28-Feb-20 Approve Issuance Plan of Write-Down Undated Capital Bonds of the Bank For Agricultural Bank of China 1288 China 28-Feb-20 Approve Issuance Plan of Write-Down Eligible Tier-2 Capital Instruments of the Bank For Aon plc AON United Kingdom 04-Feb-20 Approve Scheme of Arrangement For Aon plc AON United Kingdom 04-Feb-20 Approve Reduction of Share Capital and Creation of Distributable Profits For Aon plc AON United Kingdom 04-Feb-20 Approve Terms of an Off-Exchange Buyback and Cancellation of Class B Ordinary Shares For Aon plc AON United Kingdom 04-Feb-20 Approve Delisting of Shares from the New York Stock Exchange For Aon plc AON United Kingdom 04-Feb-20 Adjourn Meeting For Aon plc AON United Kingdom 04-Feb-20 Approve Scheme of Arrangement For Aon plc AON United Kingdom 04-Feb-20 Approve Reduction of Share Capital and Creation of Distributable Profits For Aon plc AON United Kingdom 04-Feb-20 Approve Terms of an Off-Exchange Buyback and Cancellation of Class B Ordinary Shares For Aon plc AON United Kingdom 04-Feb-20 Approve Delisting of Shares from the New York Stock Exchange For Aon plc AON United Kingdom 04-Feb-20 Adjourn Meeting For Aon plc AON United Kingdom 04-Feb-20 Approve Scheme of Arrangement For Aon plc AON United Kingdom 04-Feb-20 Approve Scheme of Arrangement For Apple Inc. AAPL USA 26-Feb-20 Elect Director James Bell For Apple Inc. AAPL USA 26-Feb-20 Elect Director Tim Cook For Apple Inc. AAPL USA 26-Feb-20 Elect Director Al Gore For Apple Inc. AAPL USA 26-Feb-20 Elect Director Andrea Jung For Apple Inc. AAPL USA 26-Feb-20 Elect Director Art Levinson For Apple Inc. AAPL USA 26-Feb-20 Elect Director Ron Sugar For Apple Inc. AAPL USA 26-Feb-20 Elect Director Sue Wagner For Apple Inc. AAPL USA 26-Feb-20 Ratify Ernst & Young LLP as Auditors For Apple Inc. AAPL USA 26-Feb-20 Advisory Vote to Ratify Named Executive Officers' Compensation For Apple Inc. AAPL USA 26-Feb-20 Proxy Access Amendments For Apple Inc. AAPL USA 26-Feb-20 Assess Feasibility of Including Sustainability as a Performance Measure for Senior Executive Compensation Against Apple Inc. AAPL USA 26-Feb-20 Report on Freedom of Expression and Access to Information Policies For Apple Inc. AAPL USA 26-Feb-20 Elect Director James Bell For Apple Inc. AAPL USA 26-Feb-20 Elect Director Tim Cook For Apple Inc. AAPL USA 26-Feb-20 Elect Director Al Gore For Apple Inc. AAPL USA 26-Feb-20 Elect Director Andrea Jung For Apple Inc. AAPL USA 26-Feb-20 Elect Director Art Levinson For Apple Inc. AAPL USA 26-Feb-20 Elect Director Ron Sugar For Apple Inc. AAPL USA 26-Feb-20 Elect Director Sue Wagner For Apple Inc. AAPL USA 26-Feb-20 Ratify Ernst & Young LLP as Auditors For Apple Inc. AAPL USA 26-Feb-20 Advisory Vote to Ratify Named Executive Officers' Compensation For Apple Inc. AAPL USA 26-Feb-20 Proxy Access Amendments For Apple Inc. AAPL USA 26-Feb-20 Assess Feasibility of Including Sustainability as a Performance Measure for Senior Executive Compensation Against Apple Inc. AAPL USA 26-Feb-20 Report on Freedom of Expression and Access to Information Policies For Apple Inc. AAPL USA 26-Feb-20 Elect Director James Bell For Apple Inc. AAPL USA 26-Feb-20 Elect Director Tim Cook For Apple Inc. AAPL USA 26-Feb-20 Elect Director Al Gore For Apple Inc. AAPL USA 26-Feb-20 Elect Director Andrea Jung For Apple Inc. AAPL USA 26-Feb-20 Elect Director Art Levinson For Apple Inc. AAPL USA 26-Feb-20 Elect Director Ron Sugar For Apple Inc. AAPL USA 26-Feb-20 Elect Director Sue Wagner For Apple Inc. AAPL USA 26-Feb-20 Ratify Ernst & Young LLP as Auditors For Apple Inc. AAPL USA 26-Feb-20 Advisory Vote to Ratify Named Executive Officers' Compensation For Apple Inc. AAPL USA 26-Feb-20 Proxy Access Amendments For Apple Inc. AAPL USA 26-Feb-20 Assess Feasibility of Including Sustainability as a Performance Measure for Senior Executive Compensation Against Apple Inc. AAPL USA 26-Feb-20 Report on Freedom of Expression and Access to Information Policies For Apple Inc. AAPL USA 26-Feb-20 Elect Director James Bell For Apple Inc. AAPL USA 26-Feb-20 Elect Director Tim Cook For Apple Inc. AAPL USA 26-Feb-20 Elect Director Al Gore For Apple Inc. AAPL USA 26-Feb-20 Elect Director Andrea Jung For Apple Inc. AAPL USA 26-Feb-20 Elect Director Art Levinson For Apple Inc. AAPL USA 26-Feb-20 Elect Director Ron Sugar For Apple Inc. AAPL USA 26-Feb-20 Elect Director Sue Wagner For Apple Inc. AAPL USA 26-Feb-20 Ratify Ernst & Young LLP as Auditors For Apple Inc. AAPL USA 26-Feb-20 Advisory Vote to Ratify Named Executive Officers' Compensation For Apple Inc. AAPL USA 26-Feb-20 Proxy Access Amendments For Apple Inc. AAPL USA 26-Feb-20 Assess Feasibility of Including Sustainability as a Performance Measure for Senior Executive Compensation Against Apple Inc. AAPL USA 26-Feb-20 Report on Freedom of Expression and Access to Information Policies For Apple Inc. AAPL USA 26-Feb-20 Elect Director James Bell For Apple Inc. AAPL USA 26-Feb-20 Elect Director Tim Cook For Apple Inc. AAPL USA 26-Feb-20 Elect Director Al Gore For Apple Inc. AAPL USA 26-Feb-20 Elect Director Andrea Jung For Apple Inc. AAPL USA 26-Feb-20 Elect Director Art Levinson For Apple Inc. AAPL USA 26-Feb-20 Elect Director Ron Sugar For Apple Inc. AAPL USA 26-Feb-20 Elect Director Sue Wagner For Apple Inc. AAPL USA 26-Feb-20 Ratify Ernst & Young LLP as Auditors For Apple Inc. AAPL USA 26-Feb-20 Advisory Vote to Ratify Named Executive Officers' Compensation For Apple Inc. AAPL USA 26-Feb-20 Proxy Access Amendments For Apple Inc. AAPL USA 26-Feb-20 Assess Feasibility of Including Sustainability as a Performance Measure for Senior Executive Compensation Against Apple Inc. AAPL USA 26-Feb-20 Report on Freedom of Expression and Access to Information Policies For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Elect KM Conlon as Director For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Elect S Summers Couder as Director For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Elect PJ Ramsey as Director For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Elect PG Etienne as Director For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Approve Grant of Performance Rights to Trevor Croker Against Aristocrat Leisure Limited ALL Australia 20-Feb-20 Approve SuperShare Plan For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Approve Remuneration Report For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Approve Renewal of Proportional Takeover Provisions For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Elect KM Conlon as Director For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Elect S Summers Couder as Director For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Elect PJ Ramsey as Director For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Elect PG Etienne as Director For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Approve Grant of Performance Rights to Trevor Croker Against Aristocrat Leisure Limited ALL Australia 20-Feb-20 Approve SuperShare Plan For Aristocrat Leisure Limited ALL Australia 20-Feb-20 Approve Remuneration Report For Aristocrat Leisure
Load more

Recommended publications
  • VARIAN MEDICAL SYSTEMS, INC. (Exact Name of Registrant As Specified in Its Charter)
    FINANCIAL HIGHLIGHTS Dollars in millions, except per share amounts 2016 2015 2014 REVENUES $ 3,218 $ 3,099 $ 3,050 GROSS MARGIN $ 1,361 $ 1,283 $ 1,302 OPERATING EARNINGS $ 551 $ 549 $ 571 OPERATING EARNINGS (as a percentage of revenues) 17.1% 17.7% 18.7% NET EARNINGS ATTRIBUTABLE TO VARIAN $ 402 $ 411 $ 404 NET EARNINGS PER DILUTED SHARE $ 4.19 $ 4.09 $ 3.83 GROSS ORDERS $ 3,400 $ 3,619 $ 3,527 BACKLOG $ 3,453 $ 3,475 $ 3,170 ORDERS & REVENUES COMBINED BUSINESSES ONCOLOGY SYSTEMS IMAGING COMPONENTS OTHER BUSINESS 4000 3000 800 350 3500 700 300 2500 3000 600 250 2000 2500 500 200 2000 1500 400 150 1500 300 1000 100 1000 200 500 50 500 100 0 0 0 0 FY16 FY15 FY14 FY16 FY15 FY14 FY16 FY15 FY14 FY16 FY15 FY14 Gross Orders Revenues EARNINGS BACKLOG 600 3500 500 400 300 3000 200 100 0 2500 FY16 FY15 FY14 Q1 Q2 Q3 Q4 Operating Earnings 2016 2015 2014 Net Earnings Attributable to Varian TO OUR STOCKHOLDERS Fiscal year 2016 was exciting for Varian. In May, we announced plans to separate our Imaging Components business into Varex Imaging Corporation, a new independent public company, through a distribution to Varian stockholders early in fiscal year 2017. Our intent with this separation is to enable our oncology and imaging components businesses to optimize their operations and focus more sharply on the unique needs of customers in their respective markets. You may recall that Varian Medical Systems is itself the product of a successful spin-off that unlocked a tremendous amount of value in three businesses.
    [Show full text]
  • VARIAN MEDICAL SYSTEMS JP Morgan Healthcare Conference - Dow Wilson, CEO
    VARIAN MEDICAL SYSTEMS JP Morgan Healthcare Conference - Dow Wilson, CEO January 13, 2015 January 2015 © 2015 VARIAN MEDICAL SYSTEMS. ALL RIGHTS RESERVED. Forward-Looking Statements • Forward-Looking Statements • Except for historical information, this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers; the company’s future orders, revenues, backlog, or earnings growth; future financial results; market acceptance of or transition to new products or technology such as our Edge™ radiosurgery system, TrueBeam™ and radiographic flat panel detectors, image-guided radiation therapy, stereotactic radiosurgery, filmless X-rays, proton therapy, and security and inspection, and any statements using the terms “could,” “believe,” “expect,” “outlook,” or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company’s actual results to differ materially from those anticipated. Such risks and uncertainties include global economic conditions; the impact of the Affordable Health Care for America Act (including excise taxes on medical devices) and any further healthcare reforms (including changes to Medicare and Medicaid), and/or changes in third-party reimbursement levels; currency exchange rates and tax rates; demand for the company’s products; the company’s ability to develop, commercialize, and deploy new products; the company’s ability to meet Food and Drug
    [Show full text]
  • Renewable Energy – Green and Profitable Is Possible Green Building in Israel Brings Home Renewable Energy
    No. 6 | December 5, 2014 Innovation Industry & Science The State of Israel – Promoting and Securing Innovative Green Energy Solutions Arava Power Company – Eventful Year of New Projects Nation-E – Making Energy Cyber Security Affordable Shikun & Binui Renewable Energy – Green and Profitable Is Possible Green building in Israel brings home renewable energy Green building and renewable energy in Israel Very quietly, without expending too much energy, hundreds of buildings are going up that are in the process of receiving green building certification. The Israeli green building standard No. 5281 validates the building’s energy efficiency. The field of green building in Israel provides opportunities for RE developers to streamline energy efficiency in buildings and turn them into energy producers. Green building and RE are two integrated fields aiming to create buildings that are healthier and more environmentally friendly. Developers, let’s build homes that produce energy themselves. www.sviva.gov.il You’re invited to take part- the future is in green building. Contents 04 Another Year and Still "Almost There…" | By Jon Cohen 08 The New Pioneers 10 Energy Cyber Security Needs to be Affordable... 19 We Seek Energy Projects with Attractive Risk/Reward Profile – Investments that “Make Sense” 24 The German-Israeli Chamber of Commerce on the Latest Trends in Making Municipal Services Greener | By Benjamin Friedländer and Gregor Schlosser * All interviews, except Shikun&Binui or if else mentioned, were conducted by Uri Schlesinger Dear Readers,
    [Show full text]
  • Company Country
    Company Country 1 Teva Pharmaceutical ISR 2 Coca-Cola HBC AG GRC 3 Bank Hapoalim ISR 4 Israel Chemicals ISR 5 Bank Leumi ISR 6 Bezeq ISR 7 Azrieli Group ISR 8 Hellenic Telecommunications Organization S.A. GRC 9 Nice Systems ISR 10 Elbit Systems ISR 11 OPAP GRC 12 Mizrahi Tefahot Bank Ltd. ISR 13 Delek Group ISR 14 Frutarom ISR 15 Osem Investments ISR 16 Israel Discount Bank ISR 17 Israel Corporation ISR 18 Hellenic Petroleum S.A. GRC 19 Gazit Globe (1982) Ltd ISR 20 BANK OF CYPRUS PUBLIC COMPANY LTD CYP 21 Titan Cement Co. S.A. GRC 22 Melisron ISR 23 Alpha Bank S.A. GRC 24 National Bank of Greece S.A. GRC 25 Paz Oil ISR 26 Strauss Group ISR 27 Folli Follie GRC 28 Motor Oil Hellas Corinth Refineries S.A. GRC 29 First Intl Bank of Israel (5) ISR 30 Public Power Corp. S.A. GRC 31 Jumbo S.A. GRC 32 Oil Refineries ISR 33 Alony Hetz Properties & Inv ISR 34 Tower Semiconductor Ltd ISR 35 Migdal Insurance & Financial Holdings Ltd. ISR 36 Grivalia Properties R.E.I.C GRC 37 Harel Investments & Finance ISR 38 Delek Automotive Systems ISR 39 Amot Investments Ltd. ISR 40 Clal Insurance ISR 41 Delta Galil Industries ISR 42 Shikun & Binui Ltd ISR 43 Airport City Ltd ISR 44 Kenon Holdings ISR 45 Athens Water Supply & Sewerage GRC 46 Ezchip Semiconductor ISR 47 Jerusalem Oil Exploration ISR 48 Phoenix Holdings ISR Company Country 49 IDI Insurance Company Ltd ISR 50 Cellcom Israel Ltd. ISR 51 Partner Communications ISR 52 VIOHALCO SA/NV (CB) GRC 53 Mytilineos Holdings S.A.
    [Show full text]
  • Migdal Insurance and Financial Holdings Ltd. and Its Subsidiaries
    Translated from the Hebrew original MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD. AND ITS SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2009 WorldReginfo - 46d726c5-4d68-401f-9270-2f760ed6a13f MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD. AND ITS SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2009 Index Page Independent Auditors’ report to the shareholders 2 Consolidated Statements of Financial Position 3 - 4 Consolidated Statements of Income 5 Consolidated Statements of Comprehensive Income 6 Consolidated Statements of Changes in Equity 7-9 Consolidated Statements of Cash Flows 10-13 Notes to the Financial Statements as at December 31, 2009 14-265 Appendix 266 - - - - - - - - - - - - WorldReginfo - 46d726c5-4d68-401f-9270-2f760ed6a13f Kost Forer Gabbay & Kasierer 3 Aminadav St. Somekh Chaikin Tel-Aviv 67067, Israel Tel: 972 (3) 6232777 Fax: 972 (3) 5633526 Independent Auditors' Report www.ey.com/il to the Shareholders of Migdal Insurance and Financial Holdings Ltd. We have audited the accompanying consolidated statements of financial position of MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD. (hereunder - the Company) as at December 31, 2009 and 2008, and the related consolidated income statements, statements of comprehensive income, statements of changes in equity, and statements of cash flows for each of the three years ended, the last of which ended, December 31, 2009. These financial statements are the responsibility of the Company's Board of Directors and Management. Our responsibility is to express an opinion on these financial statements based on our audits. We did not audit the financial statements of companies treated according to the equity value method the investment in which amounted to NIS 543,777 thousand and NIS 244,709 thousand as at December 31, 2009 and 2008, respectively, and the Group’s share in its profits amounted to NIS 87,388 thousand, NIS 58,630 thousand and NIS 51,323 thousand for each of the three years, the last of which ended December 31,2009.
    [Show full text]
  • Siemens Annual Report 2020
    Annual Report 2020 Table of A. contents Combined Management Report A.1 Organization of the Siemens Group and basis of presentation 2 A.2 Financial performance system 3 A.3 Segment information 6 A.4 Results of operations 18 A.5 Net assets position 22 A.6 Financial position 23 A.7 Overall assessment of the economic position 27 A.8 Report on expected developments and as sociated material opportunities and risks 29 A.9 Siemens AG 46 A.10 Compensation Report 50 A.11 Takeover-relevant information 82 B. Consolidated Financial Statements B.1 Consolidated Statements of Income 88 B.2 Consolidated Statements of Comprehensive Income 89 B.3 Consolidated Statements of Financial Position 90 B.4 Consolidated Statements of Cash Flows 92 B.5 Consolidated Statements of Changes in Equity 94 B.6 Notes to Consolidated Financial Statements 96 C. Additional Information C.1 Responsibility Statement 166 C.2 Independent Auditor ʼs Report 167 C.3 Report of the Super visory Board 176 C.4 Corporate Governance 184 C.5 Notes and forward-looking s tatements 199 PAGES 1 – 86 A. Combined Management Report Combined Management Report A.1 Organization of the Siemens Group and basis of presentation A.1 Organization of the Siemens Group and basis of presentation Siemens is a technology company that is active in nearly all Reconciliation to Consolidated Financial Statements is countries of the world, focusing on the areas of automation Siemens Advanta, formerly Siemens IoT Services, a stra- and digitalization in the process and manufacturing indus- tegic advisor and implementation partner in digital trans- tries, intelligent infrastructure for buildings and distributed formation and industrial internet of things (IIoT).
    [Show full text]
  • Anglia Ruskin University Faculty of Education
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Anglia Ruskin Research Online Anglia Ruskin University Faculty of Education Corporate Social and Financial Performance: The Case of Companies in Israel Yeshayahu (Shaike) Marom Thesis in partial fulfillment of the Requirements of Anglia Ruskin University For the degree of DOCTOR OF PHILOSOPY Submitted: August 2010 ACKNOWLEDGEMENTS Special thanks to my supervisors: Prof. Vernon Trafford, ARU, Chelmsford, UK: Your wide knowledge and abstract thinking lighted my way into doctorateness thinking. Dr. Andy Armitage, ARU, Chelmsford, UK: Your practical advice helped me through the hard work of Ph.D. thesis. To the Anglia Ruskin University staff that was very supportive throughout my research: Dr. Gill Robinson, ARU, UK Professor. Gina Wisker, ARU, UK To the Israeli Ph.D. coordinators: Mr. Dani Shenkar Mr. Avishai Tal i TABLE OF CONTENTS ABSTRACT ............................................................................................................ viii CHAPTER 1 INTRODUCTION................................................................................1 CORPORATE SOCIAL RESPONSIBILITY .........................................................................1 CSR IMPACT ON FINANCIAL PERFORMANCE ...............................................................2 PREVIOUS EMPIRICAL RESEARCH ................................................................................5 CONTEXT SETTING ......................................................................................................5
    [Show full text]
  • Bluestar Israel Equity Update First Quarter 2014
    BlueStar Israel Equity Update First Quarter 2014 Q4 2013 in Review & 2014 Outlook All major global developed market equity benchmarks rose strongly in Q4 2013 despite the announcement of the Federal Reserve’s intentions to reduce the scope of its bond purchase What’s Inside program The BlueStar Israel Global Index rose 10.54% in Q4 2013 on an annualized basis while the TA-100 and MSCI Israel indices were up 7.38% and 6.34%, respectively. The BlueStar 1. Israeli Global benchmark also outperformed the TA-100 and MSCI Israel benchmarks for the full year 2013 by 4 and 15 percentage points, respectively. Equities in Q4 2013 For the second straight quarter the rally in Israeli equities was broad based and in each of the three largest sectors: Information Technology, Financials and Health Care. Additionally a long-awaited recovery in the telecom sector took hold during the quarter. Each of these sectors rose strongly during Q4 2013 indicating strength in the domestic economy and an 2.-6. About the BIGI & acceleration in the growth rates of the economies of Israel’s largest trading partners. BIGTech Indexes, The Israeli government budget deficit continued to shrink bringing on the prospect of lower Rebalance Review, taxes and higher government spending in 2014. The labor force participation rate rose in the and Risk/Return fourth quarter while the unemployment rate remained low. Data The revival in trading volume on the TASE, rise in equity prices in most developed countries, and several relatively large IPOs by Israeli companies during the second half of 2014 resulted in a net addition of 12 companies in the BlueStar Israel Global Index’s December rebalance.
    [Show full text]
  • Annual Report 2018
    Annual Report 2018 siemens-healthineers.com Table of contents Page 02 Report of the Supervisory Board Page 10 To our shareholders A. B. C. Combined Consolidated Additional management financial information report statements Page 16 Page 58 Page 104 A.1 Business environment B.1 Consolidated C.1 Responsibility statements of statement Page 18 income A.2 Economic environment Page 105 Page 59 C.2 Independent auditor’s Page 20 B.2 Consolidated report A.3 Financial performance statements of system comprehensive Page 110 income C.3 Corporate Governance Page 21 A.4 Results of operations Page 60 Page 118 B.3 Consolidated C.4 Notes and Page 23 statements of forward-looking A.5 Assets position financial position statements Page 24 Page 61 A.6 Financial position B.4 Consolidated statements of Page 26 cash flows A.7 Overall assessment of Page 62 the economic position B.5 Consolidated Page 27 statements of changes in equity A.8 Nonfinancial matters Page 63 Page 28 B.6 Notes to consolidated A.9 Report on expected financial statements developments Page 30 A.10 Report on material risks and opportunities Page 37 A.11 Siemens ­Healthineers AG Page 39 A.12 ­Remuneration report Page 52 A.13 ­Takeover-relevant information and explanatory report Siemens Healthineers Annual Report 2018 Report of the Supervisory Board “ Thanks to the depth and breadth of its portfolio, ­­Siemens Healthineers is ideally positioned to meet the challenges of worldwide population growth and increasing life expectancies.” Michael Sen Chairman of the Supervisory Board 02 Siemens Healthineers Annual Report 2018 Report of the Supervisory Board Fiscal year 2018 represented a milestone in the corporate history of both, Siemens and ­­Siemens Healthineers.
    [Show full text]
  • Israel's High-Tech Figures
    High-Tech Industries Israel’s High-Tech Figures Israel has become one of the world’s most highly regarded and 2001. He joined the company in 1994, and is serving as a director important high-tech centers and high-tech is the main growth in some of Elron's subsidiaries. engine of Israel’s economy. In 2004, Israeli high-tech sales exceeded $15 billion, including $12.9 billion in exports. In the Davidi Gilo – One of the most important inventors and peak year of 2000, no less than 3,000 high-tech start-ups were entrepreneurs of the Israeli high-tech industry. Gilo is also the active in Israel – one start-up per 2,000 residents. man responsible for one of biggest high-tech deals in Israeli history – the purchase of DSPC (DSP Communications), a This chapter presents the figures standing behind the impressive wireless communications chip designer, by Intel (1999), in a deal activities of Israel’s high-tech industries. Israel’s high-tech worth $1.6 billion. community is characterized by a high concentration of talent, Gilo established the DSPC Group in the United States, but its energy and innovation. We’ve chosen to focus on a number R&D centers were located in Israel. of issues important to Israeli high-tech, featuring some of the personalities. Benny Peled (deceased) – Major General (Res.) Benny Peled, former Commander of the Israeli Air Force (1973-1977), Founding Fathers served as president of Elbit and its subsidiary Elscint. Peled turned Elbit into one of the most important providers of defense Efi Arazi – The “wonder kid” of the Israeli economy, is best systems and equipment in Israel and abroad.
    [Show full text]
  • Elron Electronic Industries Ltd. (The “Company”) *** Shelf Prospectus
    English Translation, for Convenience Purposes Only, of the Hebrew Shelf Prospectus submitted to the Israeli Securities Authority and Tel Aviv Stock Exchange Ltd. The following translation is intended solely for the convenience of the reader. This translation has no legal status and although every effort has been made to ensure its accuracy, the Company does not assume any responsibility whatsoever as to its accuracy and is not bound by its contents. Only the original Hebrew text is binding and reader is advised to consult the Hebrew text in all matters which may affect them. Elron Electronic Industries Ltd. (the “Company”) *** Shelf Prospectus According to this Shelf Prospectus, the Company may issue various types of securities according to the provisions of the law, including: shares, non-convertible debentures (including through the expansion of existing debentures series of the Company, as may be from time to time), debentures convertible into shares (including through the expansion of existing convertible debentures series, as may be from time to time), warrants exercisable into shares, warrants exercisable into non-convertible debentures, warrants exercisable into debentures that are convertible into shares, commercial securities and any other security which can lawfully be issued under a shelf prospectus on the relevant date (the "Offered Securities"). The offering of securities under this Shelf Prospectus shall be made pursuant to the provisions of Section 23A(f) of the Israel Securities Law 5728-1968, through shelf offering reports in which all the details specific to such offerings will be completed, including the details and terms and conditions of the securities and the composition of the offered units, according to the provisions of any law and according to the rules and guidelines of the Tel Aviv Stock Exchange Ltd., as they shall be at that time.
    [Show full text]
  • VARIAN Medical Systems Inc(2).Pdf
    Jefferies Conference November 2017 J. Michael Bruff Vice President Investor Relations [email protected] This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. FORWARD-LOOKING STATEMENTS Except for historical information, this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers, future trends in cancer incidence and trends in cancer treatment needs, demand, innovation and growth opportunities; Varian Medical System, Inc.’s (”Varian” or the “company”) future orders, revenues, backlog or earnings growth; future financial results; market acceptance of or transition to new products or technology such as our EdgeTM radiosurgery system, TrueBeam®, HyperArcTM, 360 OncologyTM, HALCYONTM, image-guided radiation therapy, stereotactic radiosurgery and proton therapy, and any statements using the terms “could”, “believe”, “expect”, “outlook”, “anticipate”, ”vision”, “estimate”, “future”, “horizon”, “aiming”, “driving”, “target” or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company’s actual results to differ materially from those anticipated. Such risks and uncertainties include global economic conditions and changes to trends for cancer treatment regionally; the impact of changes to the Affordable Health Care for America Act (including excise taxes on medical devices) and any further healthcare
    [Show full text]